Geneva, March 20 -- International Clinical Trials Registry received information related to the study (CTRI/2026/02/104730) titled 'Effect Of Sarjarasa taila Application In Scabies In Children' on Feb. 25.
Study Type: Interventional
Study Design:
Randomized, Parallel Group Trial Method of generating randomization sequence:Other Method of allocation concealment:Alternation Blinding and masking:Open Label
Primary Sponsor: Dr Hemangi Shivaji Yewale
Condition:
Health Condition 1: B86- Scabies
Recruitment Status: Not Recruiting
Phase: Phase 3
Date of First Enrollment: 11-04-2026
Target Sample Size: 68
Countries of Recruitment:
India
To know more, visit http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=155856
Publi...